Nitza Goldenberg-Cohen Selected Research

Bevacizumab (Avastin)

1/2016	Comparison of Neuroprotective Effect of Bevacizumab and Sildenafil following Induction of Stroke in a Mouse Model.
12/2013	Effect of intravitreal injection of bevacizumab on optic nerve head leakage and retinal ganglion cell survival in a mouse model of optic nerve crush.
11/2009	Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nitza Goldenberg-Cohen Research Topics

Disease

6	Neoplasms (Cancer) 05/2021 - 10/2007
4	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 12/2012 - 04/2008
3	Inflammation (Inflammations) 12/2022 - 01/2016
3	Gliosis 12/2022 - 12/2012
3	Glioma (Gliomas) 01/2022 - 01/2012
3	Ischemia 01/2014 - 10/2008
3	Hypoxia (Hypoxemia) 03/2012 - 10/2008
2	Glaucoma 12/2022 - 07/2005
2	Ganglion Cysts (Ganglion) 12/2022 - 12/2011
2	Medulloblastoma 05/2021 - 01/2018
2	Basal Cell Carcinoma (Rodent Ulcer) 05/2021 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 02/2016
2	Stargardt Disease 01/2020 - 02/2019
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020 - 02/2019
2	Cone-Rod Dystrophies 01/2020 - 02/2019
2	Usher Syndromes (Usher Syndrome) 02/2019 - 01/2013
2	Chemical Burns (Chemical Burn) 01/2019 - 11/2009
2	Optic Nerve Diseases (Optic Neuropathy) 01/2019 - 09/2009
2	Stroke (Strokes) 01/2019 - 01/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2011
2	Corneal Neovascularization 01/2019 - 11/2009
2	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2010
2	Blindness (Hysterical Blindness) 01/2016 - 01/2011
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 01/2016
2	Edema (Dropsy) 01/2016 - 12/2013
2	Cataract (Cataracts) 07/2012 - 11/2010
2	Retinal Artery Occlusion 09/2011 - 07/2005
2	Uveal melanoma 12/2010 - 10/2007
2	Melanoma (Melanoma, Malignant) 12/2010 - 07/2003
2	Pain (Aches) 06/2010 - 10/2008
2	Strabismus (Squint) 06/2010 - 10/2008
2	Macular Degeneration (Age-Related Maculopathy) 01/2008 - 01/2008
1	Exophthalmos (Proptosis) 11/2020
1	Rhabdomyosarcoma 11/2020
1	Arteriovenous Malformations (Arteriovenous Malformation) 11/2020
1	Capillary Hemangioma 11/2020
1	Choroidal Effusions 01/2019
1	Low Vision (Subnormal Vision) 01/2019
1	Uveitis 01/2019
1	Horner Syndrome (Horner's Syndrome) 01/2019
1	Hypothyroidism 01/2019
1	Neuroblastoma 01/2019
1	Obesity 01/2019
1	Carcinogenesis 01/2018
1	Cerebral Palsy (Spastic Diplegia) 01/2016
1	Brain Edema (Cerebral Edema) 01/2016
1	Brain Infarction 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016
1	Asphyxia (Suffocation) 01/2016
1	Infarction (Infarctions) 01/2016
1	Hydrocephalus (Hydrocephaly) 01/2016

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 12/2022 - 10/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2008
4	Neuroprotective AgentsIBA 01/2016 - 09/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2008
3	Oxygen (Dioxygen)IBA 01/2016 - 01/2011
3	Bevacizumab (Avastin)FDA Link 01/2016 - 11/2009
3	Caspase 3 (Caspase-3)IBA 03/2012 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2010
2	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2018
2	GoldIBA 01/2020 - 02/2016
2	Sildenafil Citrate (Viagra)FDA Link 01/2019 - 01/2016
2	Glial Fibrillary Acidic ProteinIBA 01/2019 - 09/2015
2	Toll-Like Receptor 4IBA 01/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2018 - 10/2008
2	triphenyltetrazoliumIBA 01/2016 - 01/2016
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 12/2011 - 01/2011
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2011 - 09/2009
2	CytokinesIBA 04/2008 - 07/2005
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2008 - 10/2007
2	sodium bisulfite FDA Link 02/2008 - 10/2007
1	PlasticsIBA 12/2022
1	Metalloproteases (Metalloproteinases)IBA 05/2021
1	Connexin 30IBA 05/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	AntibodiesIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	HhAntag691IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Myelin Basic ProteinIBA 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2019
1	GelatinIBA 01/2019
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2019
1	Vanilmandelic Acid (Vanillylmandelic Acid)IBA 01/2019
1	Superoxide DismutaseIBA 01/2019
1	Silver NitrateIBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	potassium nitrate (saltpeter)IBA 01/2019

Therapy/Procedure

3	Lasers (Laser) 11/2020 - 11/2009
2	Radiotherapy 05/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 11/2020 - 11/2015
2	Therapeutics 01/2016 - 01/2012
1	Injections 12/2022
1	Microspheres (Microsphere) 12/2022
1	Anesthesia 01/2019
1	Operative Surgical Procedures 02/2016
1	Ventriculoperitoneal Shunt 01/2016